GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Vicarious Surgical Inc.
Vicarious Surgical develops next-generation robotic surgical systems. Its stock price represents a venture bet that its technology will compete with market leader Intuitive Surgical. The chart reflects contingency on FDA approvals and commercialization.
Share prices of companies in the market segment - Therapeutic medical equipment
Vicarious Surgical is a next-generation robotics company developing miniature robots for minimally invasive surgeries. We've categorized it as a "Therapeutic Medical Device" company. The chart below shows how investors view the future of robotic surgery.
Broad Market Index - GURU.Markets
Vicarious Surgical is a company developing next-generation robotic surgical systems that use virtual reality for minimally invasive procedures. As a component of the GURU.Markets index, it represents the future of surgery. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
RBOT - Daily change in the company's share price Vicarious Surgical Inc.
For Vicarious Surgical Inc., a developer of surgical robots, daily volatility reflects sensitivity to news about developments and FDA approvals. This metric is an important element for analyzing companies in the MedTech sector.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Vicarious Surgical Inc. is a developer of surgical robots. This chart highlights the extreme volatility of the MedTech sector. Comparison with RBOT's performance helps assess it as a high-risk asset dependent on technological breakthroughs and FDA approvals.
Daily change in the price of a broad market stock, index - GURU.Markets
Vicarious Surgical is developing a next-generation robotic surgical system. The company's shares are a venture bet on a breakthrough in medical robotics. Their high, speculative volatility is part of the dynamics of the innovation sector, which influences the entire market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Vicarious Surgical Inc.
Vicarious Surgical's year-over-year performance is a story about the development of a new generation of surgical robots. Its 12-month market cap depends entirely on progress in developing and securing FDA approval for its robotic system. Every successful engineering and regulatory step is fundamental to validating its ambitious concept.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Vicarious Surgical Inc. is developing a next-generation robotic surgical system. Its stock price is entirely speculative and based on investors' faith in its ability to commercialize its breakthrough technology and compete with the dominant Intuitive Surgical, rather than on current financial results.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vicarious, which develops surgical robots, is a highly speculative stock. Its performance isn't tied to economic cycles, but rather depends on its ability to secure regulatory approval and compete with the giants. Its chart is a tale of hope and disappointment, typical of medtech startups.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Vicarious Surgical Inc.
Vicarious Surgical is developing next-generation surgical robots. While still in the development stage, its monthly valuation is based on expectations. News about technological milestones, system testing, and progress toward FDA approval are the primary drivers.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Vicarious Surgical is developing next-generation surgical robots. The robotic surgery sector is growing rapidly, promising less invasive and more precise procedures. The chart below shows how investors assessed the prospects of new players challenging the dominance of existing systems, and how much confidence they placed in their technological advantages.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vicarious Surgical is developing next-generation surgical robots, betting on the next wave of automation in medicine. The company's stock price depends on technological advances, successful trials, and regulatory approvals, not the state of the economy.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Vicarious Surgical Inc.
Vicarious Surgical is developing a new generation of surgical robots. Weekly stock performance is highly volatile and depends on key news: progress toward FDA approval, preclinical and clinical trial results, and competition in the rapidly growing medical robotics market.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a new generation of surgical robots. Weekly stock performance is highly volatile and depends on key news: progress toward FDA approval, preclinical and clinical trial results, and competition in the rapidly growing medical robotics market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Vicarious, a surgical robotics company, lives in a world of its own. Its performance is driven by news of regulatory approvals. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can rise or fall, completely ignoring the broader market.
Market capitalization of the company, segment and market as a whole
RBOT - Market capitalization of the company Vicarious Surgical Inc.
Vicarious Surgical's market capitalization chart is a futuristic story about the development of a new generation of surgical robots. Its sharp decline after its SPAC exit reflects investor skepticism and the long, expensive road to commercialization. It's a visualization of how difficult it is to compete with giant Intuitive Surgical and live up to the initial hype.
RBOT - Share of the company's market capitalization Vicarious Surgical Inc. within the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system. Its share of its segment's market capitalization reflects investors' faith in its breakthrough technology. The chart below shows the high volatility of its valuation as the company moves from development to commercial launch.
Market capitalization of the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system, aiming to make surgeries more precise and less invasive. The chart below shows the overall market capitalization of the therapeutic medical equipment sector. It reflects the technology race in robotic surgery, where Vicarious competes with the giants.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graphic shows robots in an operating room. Vicarious Surgical is developing a robotic system for minimally invasive surgery. Their line is a bet that their more compact and affordable robot will be able to compete with giant Intuitive Surgical (creator of the da Vinci).
Book value capitalization of the company, segment and market as a whole
RBOT - Book value capitalization of the company Vicarious Surgical Inc.
Vicarious Surgical's capital consists of its intellectual property for a robotic surgical system that combines virtual reality and miniature robots, as well as its financial reserves. This is the capital for revolutionizing surgery. The chart shows how the company is accumulating and spending vast amounts of funds to develop and secure approval for its futuristic system.
RBOT - Share of the company's book capitalization Vicarious Surgical Inc. within the market segment - Therapeutic medical equipment
Vicarious Surgical is developing next-generation surgical robots. Its assets include R&D centers and production lines for assembling these complex systems. The chart shows the company's share of this nascent, high-tech physical infrastructure for robotic surgery.
Market segment balance sheet capitalization - Therapeutic medical equipment
Robotic surgery, as the BCap_Ges chart shows, is an extremely capital-intensive sector. Vicarious Surgical, in developing its surgical robot, must invest colossal amounts of money in R&D and precision manufacturing. The chart confirms the high barriers to entry.
Book value of all companies included in the broad market index - GURU.Markets
Vicarious Surgical's balance sheet is comprised of the capital and prototypes of its next-generation surgical robot. Its value reflects the financial and engineering resources needed to create a machine that promises to make minimally invasive surgeries more accessible and precise.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Vicarious Surgical Inc.
Vicarious Surgical is developing a next-generation robotic surgical system. Its book value reflects prototypes and R&D. Its market capitalization reflects the hope that its robot will challenge the dominance of the da Vinci system. The MvsBCap chart is a story of faith and doubt in its ability to revolutionize surgery.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system. Its valuation is based on the potential of its breakthrough technology. The chart demonstrates the high expectations of investors regarding the future of robotic surgery.
Market to book capitalization ratio for the market as a whole
Vicarious Surgical is developing a next-generation robotic surgical system. Its goal is to make surgeries less invasive. The company's value lies in its innovative technology and patents. The chart shows how investors are betting on the next generation of surgical robots, which could challenge current market leaders.
Debts of the company, segment and market as a whole
RBOT - Company debts Vicarious Surgical Inc.
Vicarious Surgical, a company developing a new generation of surgical robots, is devoting its entire capital to R&D, testing, and regulatory approval. Building a complex robotic system from scratch is a ten-year, extremely expensive process. This chart shows how the company is funding its attempt to revolutionize minimally invasive surgery.
Market segment debts - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system. The creation and commercialization of complex medical robots is an extremely capital-intensive and time-consuming process. This chart illustrates how the company is funding its ambitious developments to compete with the giants of the robotic surgery market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Vicarious Surgical Inc.
Vicarious Surgical is developing next-generation surgical robots. This chart shows how much debt the company is raising to finance its ambitious R&D. High debt in this sector is an investment in the future, but it carries enormous risks if the regulatory approval and commercialization process is delayed.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system. The chart shows the overall debt burden in the medical technology sector. It helps assess how the company is funding its ambitious and expensive developments, striving to breakthrough in a market already occupied by strong competitors.
Debt to book value of all companies in the market
Vicarious Surgical develops next-generation robotic surgical systems. For a company operating in the capital-intensive medical technology sector, the overall financial climate, reflected in this chart, is critical. Hospital budgets for expensive equipment and the availability of venture capital depend on the health of the economy.
P/E of the company, segment and market as a whole
P/E - Vicarious Surgical Inc.
For Vicarious Surgical, a developer of next-generation surgical robots, this chart reflects investor confidence in the future of robotic surgery. High values ββindicate expectations that its smaller, more maneuverable robots will revolutionize operating rooms by making surgeries less invasive.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average P/E ratio for the surgical robotics sector, where Vicarious Surgical is an innovator. The industry's high valuation reflects expectations for the future of surgery. This metric helps understand the premium the market places on Vicarious's technology compared to the giant Intuitive Surgical.
P/E of the market as a whole
Vicarious Surgical is developing a next-generation robotic surgical system that uses miniature robots controlled via virtual reality. The goal is to make surgeries less invasive. This chart shows sentiment in the medtech sector. It helps understand whether the market believes Vicarious's technology can challenge the dominance of existing robotic platforms, such as the da Vinci.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Vicarious Surgical Inc.
Vicarious Surgical is developing a next-generation robotic surgical system that aims to make surgeries less invasive. The company's valuation is a bet on its technology. This chart reflects analysts' expectations for the company's ability to secure regulatory approval and convince surgeons to adopt its new platform.
Future (projected) P/E of the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a robotic surgical system that uses virtual reality to create an immersive experience for surgeons. This chart shows how its future revenue expectations compare to the industry average. Does the market believe its approach will be the next step in the evolution of robotic surgery?
Future (projected) P/E of the market as a whole
Vicarious Surgical is developing a new generation of surgical robots. This is a capital-intensive business, requiring significant investment in R&D and commercialization. This market valuation chart shows how much investors are willing to pay for breakthrough medical technologies. Market optimism is making it easier for Vicarious Surgical to attract the necessary funding.
Profit of the company, segment and market as a whole
Company profit Vicarious Surgical Inc.
Vicarious Surgical Inc. is developing a next-generation robotic surgical system that mimics human surgeons' movements. The company's financial status reflects development costs and regulatory approvals. This chart shows the path to commercialization, with every dollar invested in the creation of a robot that promises to make surgeries more precise.
Profit of companies in the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical platform that uses miniature robots controlled through a surgeon's VR headset. This chart shows the overall profitability of the medical robotics sector, where innovations are aimed at making surgeries even less invasive, more precise, and more accessible.
Overall market profit
Vicarious Surgical is developing a next-generation robotic surgical system. Bringing such complex medical equipment to market requires significant investment. This schedule, reflecting market conditions, impacts the company's ability to raise capital to complete development, obtain approvals, and commercialize it.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Vicarious Surgical Inc.
Vicarious Surgical is developing a next-generation robotic surgical system that uses virtual reality and miniature robots to perform minimally invasive surgeries. This chart summarizes analyst forecasts, betting on the success of this futuristic technology and its ability to conquer the market.
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system. Using miniature robots and virtual reality, the company aims to make minimally invasive surgeries even more precise and accessible. This chart shows profitability forecasts for the medical device sector, reflecting the high expectations for the next wave of innovation in robotic surgery.
Future (predicted) profit of the market as a whole
Vicarious Surgical develops next-generation robotic surgical systems. The implementation of such expensive systems depends on hospital capital budgets. The overall corporate profit forecast presented in this chart provides insight into the economic climate that impacts the healthcare system's financial capacity and its readiness for major investments.
P/S of the company, segment and market as a whole
P/S - Vicarious Surgical Inc.
Vicarious Surgical is developing next-generation surgical robots. This chart shows its estimated future potential. For a company whose product has yet to reach the mass market, its high market cap reflects investors' hopes that its technology will revolutionize surgery.
P/S market segment - Therapeutic medical equipment
Vicarious Surgical Inc. is developing a next-generation robotic surgical system designed to minimize the invasiveness of surgeries. This chart shows the average revenue estimate for the medical device sector. It provides an indication of how investors view the company's technology's potential to revolutionize the robotic surgery market.
P/S of the market as a whole
Vicarious Surgical is developing a next-generation robotic surgical system that uses virtual reality and miniature robots to perform minimally invasive surgeries. Their goal is to revolutionize surgery. This chart, showing valuations of companies with actual revenue, highlights the enormous expectations investors have for breakthrough medical technologies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Vicarious Surgical Inc.
Vicarious Surgical is developing a next-generation robotic surgical system that uses virtual reality to create an immersive experience. This chart reflects investors' confidence in the future of robotic surgery. The valuation is based on the potential of its technology to make minimally invasive surgeries more accessible and effective.
Future (projected) P/S of the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system that uses virtual reality and miniature robots to perform minimally invasive surgeries. This chart shows how investors view its breakthrough technology compared to the medical device sector.
Future (projected) P/S of the market as a whole
Vicarious Surgical is developing a next-generation robotic surgical system. This schedule, reflecting hospitals' willingness to invest in expensive equipment, is important for the company's future. Economic growth and a stable healthcare system allow medical institutions to plan for major capital expenditures, such as the purchase of innovative surgical robots.
Sales of the company, segment and market as a whole
Company sales Vicarious Surgical Inc.
Vicarious Surgical is developing a next-generation robotic surgical system designed to minimize the invasiveness of surgeries. This chart reflects funding during the development stage, not commercial sales. It illustrates the investment in creating a breakthrough technology that could change the future of surgery.
Sales of companies in the market segment - Therapeutic medical equipment
Vicarious Surgical Inc. is developing a new generation of robotic surgical systems, aiming to make surgeries more precise and less invasive. While still in the development stage, its business can be roughly divided by the potential surgical applications of its technology. This chart may reflect revenue from partnerships related to one of these areas.
Overall market sales
Vicarious Surgical Inc. is developing a next-generation robotic surgical system that uses virtual reality to create an immersive experience. The goal is to make surgeries more precise and less invasive. The company is at the forefront of medical technology, and its success could change the future of surgery, which is part of the innovation economy.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Vicarious Surgical Inc.
Vicarious Surgical is developing a next-generation robotic surgical system that uses virtual reality and miniature robots to perform minimally invasive surgeries. Future sales projections are a bet that its technology will offer significant advantages over existing systems and be adopted by surgeons.
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system, aiming to minimize the invasiveness of surgeries. This graph reflects expectations for the entire medical device sector. It helps assess the pace of robotic surgery adoption and the demand analysts predict for innovative surgical platforms.
Future (projected) sales of the market as a whole
Vicarious Surgical is developing next-generation surgical robots. Demand for these expensive systems depends on hospital capital budgets. This chart of overall sales forecasts reflects the economic climate that allows medical institutions to invest in cutting-edge technologies.
Marginality of the company, segment and market as a whole
Company marginality Vicarious Surgical Inc.
Vicarious Surgical Inc. is developing a next-generation robotic surgical system, aiming to minimize the invasiveness of surgeries. While in the development stage, the company incurs significant R&D expenses. This chart illustrates its current financial position, where investments in breakthrough technology are the foundation for future growth.
Market segment marginality - Therapeutic medical equipment
Vicarious Surgical is developing a robotic surgical system designed to minimize the invasiveness of surgeries. Profitability in this capital-intensive field depends on technological superiority and successful passage of regulatory hurdles. The chart shows their operating costs as they move toward commercialization of their robot.
Market marginality as a whole
Vicarious Surgical Inc. is developing a next-generation robotic surgical system that uses virtual reality to create an immersive experience for surgeons. This chart reflects the profitability of mature medtech companies, but for RBOT, breakthrough technology, promising miniaturization and improvement of robotic surgery, is key to future value.
Employees in the company, segment and market as a whole
Number of employees in the company Vicarious Surgical Inc.
Vicarious Surgical is developing a next-generation robotic surgical system. This chart shows the large and growing team of robotic engineers. The team's significant size reflects the massive investment in R&D required to develop, test, and commercialize such a complex medical device.
Share of the company's employees Vicarious Surgical Inc. within the market segment - Therapeutic medical equipment
Vicarious Surgical is developing next-generation surgical robots using virtual reality. Creating such a complex system is a challenge for an elite team of robotic engineers. This achievement reflects their ambition and investment in the future of surgery.
Number of employees in the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system. This chart shows employment in the therapeutic medical equipment sector. The growing number of robotic engineers and surgeons indicates a high demand for less invasive and more precise surgical procedures, which is Vicarious Surgical's primary goal.
Number of employees in the market as a whole
Vicarious Surgical is developing a new generation of surgical robots. The medical robotics sector is growing thanks to the desire to minimize the invasiveness of surgeries. This technological trend is a more important driver for Vicarious than the overall labor market situation, as shown in this chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Vicarious Surgical Inc. (RBOT)
Vicarious Surgical Inc. develops robotic surgical systems. This is a highly knowledge- and capital-intensive field. The high market capitalization per employee in this chart reflects the enormous value of intellectual property and complex engineering work being carried out by its elite team of engineers.
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Vicarious Surgical Inc. is developing a new generation of surgical robots using virtual reality. In the medical robotics sector, this metric reflects the market valuation of their breakthrough technology and intellectual property. It demonstrates the extent to which investors believe in the team's ability to change the future of surgery.
Market capitalization per employee (in thousands of dollars) for the overall market
Vicarious Surgical Inc. is developing a next-generation robotic surgical system that aims to miniaturize robotics and utilize virtual reality to enhance visualization. The chart reflects the market's high expectations for breakthroughs in medical robotics.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Vicarious Surgical Inc. (RBOT)
Vicarious Surgical is attempting to revolutionize surgery with its robotic system, which combines VR and miniature robots to perform single-incision surgeries. It's a pre-commercial R&D company. This graph (deeply negative) shows how much capital is being burned per robotics engineer and physician to create this futuristic, yet incredibly complex, medical system.
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Vicarious Surgical is developing a next-generation robotic surgical system, aiming to minimize the invasiveness of surgeries. In the medtech robotics sector, value is created by a team of highly skilled engineers. This metric reflects how effectively their R&D efforts translate into company value and serves as a benchmark against other market players.
Profit per employee (in thousands of dollars) for the market as a whole
Vicarious Surgical (RBOT) is developing next-generation surgical robots. This is a capital-intensive R&D business. The company is in the pre-commercial stage. Its negative profit per employee reflects the enormous investment in the team of engineers and surgeons who must create and certify this complex system.
Sales to employees of the company, segment and market as a whole
Sales per company employee Vicarious Surgical Inc. (RBOT)
Vicarious Surgical is developing a next-generation robotic surgical system. While the company is still in the approval stage, it has not yet generated commercial revenue. This timeline will ultimately determine whether its innovative technology can gain market share and deliver high performance.
Sales per employee in the market segment - Therapeutic medical equipment
Vicarious Surgical is developing next-generation surgical robots, combining robotics and VR to give surgeons "superpowers" during minimally invasive procedures. This chart compares revenue per employee (R&D) to the industry average, demonstrating how productive their futuristic technology is on the road to commercialization.
Sales per employee for the market as a whole
Vicarious Surgical (RBOT) is developing a new generation of surgical robots, combining robotics and virtual reality. Their goal is to compete with Intuitive Surgical. This is an R&D company in the pre-commercialization stage. The company has no sales revenue. This graph will reflect $0, as all employees (engineers) are focused on robot development.
Short shares by company, segment and market as a whole
Shares shorted by company Vicarious Surgical Inc. (RBOT)
Vicarious Surgical (RBOT) is a company (formerly a SPAC) developing a next-generation surgical robot. They are challenging giant Intuitive Surgical (da Vinci). It's an incredibly expensive and complex market. This chart shows the number of investors who don't believe Vicarious can build a better robot than the leader and navigate the complex FDA approval process.
Shares shorted by market segment - Therapeutic medical equipment
Vicarious Surgical is attempting to revolutionize surgery by using robots and virtual reality to perform minimally invasive procedures. This chart shows the odds against the surgical robotics sector, reflecting investor skepticism that new players will be able to displace the dominant da Vinci system.
Shares shorted by the overall market
Vicarious Surgical is developing next-generation surgical robots. It's an extremely capital-intensive business. This chart illustrates the general fear among investors. When the market is fearful, it's unwilling to fund lengthy R&D and certification. He doubts that during a recession, hospitals will spend millions on new, even groundbreaking, robotic systems.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Vicarious Surgical Inc. (RBOT)
Vicarious Surgical is an ambitious company aiming to revolutionize surgery with its VR-enabled robots. It's a classic venture capital story: high risks, but also enormous potential. This indicator tracks speculative interest, showing when the hype around their technology (above 70) is overheating the stock, or when FDA approval delays (below 30) are causing panic.
RSI 14 Market Segment - Therapeutic medical equipment
Vicarious Surgical Inc. is developing a next-generation robotic system for minimally invasive surgeries. It's a clear bet on revolutionizing surgery. This chart tracks the collective momentum in the therapeutic medical device and surgical robotics sectors. It helps us understand whether RBOT's momentum is unique or reflects a general overheating of the medtech sector.
RSI 14 for the overall market
For Vicarious Surgical (RBOT), a developer of surgical robots, this chart is their lifeline. In a euphoric mood, investors are ready to fund the "future of medicine," and hospitals are ready to buy expensive robots. In a panic, investors flee unprofitable R&D projects, and hospitals freeze capital expenditures, which is a double whammy.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RBOT (Vicarious Surgical Inc.)
Vicarious Surgical is developing a next-generation surgical robot that combines virtual reality and miniaturization for minimally invasive surgeries. This chart shows the average target price. Analysts' forecasts are based on success in obtaining FDA approval and the robot's potential to compete with Intuitive Surgical.
The difference between the consensus estimate and the actual stock price RBOT (Vicarious Surgical Inc.)
Vicarious Surgical is a futuristic company developing a new generation of surgical robots with human-like mobility. This chart measures the gap between the current share price and the consensus target price. It shows the enormous, yet risky, potential analysts see in their technology and its ability to challenge the giants (Intuitive Surgical).
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Vicarious Surgical is a "surgical avatar." The company is developing a surgical robot (a "human-in-the-loop" system) that uses VR to "immerse" the surgeon inside the patient. This chart shows general expectations for the therapeutic medical equipment sector. It reflects whether experts believe in the next generation of "VR robots."
Analysts' consensus forecast for the overall market share price
Vicarious Surgical is a company developing a next-generation robotic surgical system that uses VR and miniature robots to perform surgeries "from within" the abdomen. This chart shows the overall risk appetite. For Vicarious, a company with a revolutionary but capital-intensive technology, overall market optimism (risk appetite) is critical for funding R&D.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Vicarious Surgical Inc.
Vicarious Surgical is a surgical robot 2.0. They're developing a single-port robot that (theoretically) will enter the body through a single incision and feature humanoid arms for abdominal surgeries. This chart is pure hype and R&D. It reflects their (very long) and risky path to FDA approval and their race against the giants (Intuitive Surgical).
AKIMA Market Segment Index - Therapeutic medical equipment
Vicarious Surgical (RBOT) is developing a next-generation robotic surgical system that combines miniature robots and VR to give surgeons superhuman capabilities inside patients. The chart shows the segment's average index, helping investors assess how this futuristic technology stacks up against the dominant players in the medical device sector.
The AKIM Index for the overall market
Vicarious Surgical is a developer of next-generation surgical robots using VR and miniature instruments for abdominal surgery. This chart, reflecting the market average, is just the background. It helps assess how this ambitious MedTech startup, still in development, stacks up against overall macroeconomic trends.